Results 191 to 200 of about 193,010 (259)

Evolutionary trade‐offs between beauvericin production and growth define divergent virulence strategies in Beauveria

open access: yesPest Management Science, EarlyView.
Two virulence strategies in Beauveria: a growth strategy characterized by rapid within‐host proliferation, and a toxin strategy involving antimicrobial activity and toxicity to insects Abstract BACKGROUND Pathogen virulence is often attributed to toxin production, yet toxins are metabolically costly and may not universally enhance fitness.
Shasha Hu   +3 more
wiley   +1 more source

Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for <i>Pseudomonas aeruginosa</i> infections: a GRADE-assessed systematic review and meta-analysis. [PDF]

open access: yesAnn Med Surg (Lond)
Shah A   +10 more
europepmc   +1 more source

Single and dual RPA‐CRISPR/Cas assays for point‐of‐need detection of Stewart's wilt pathogen (Pantoea stewartii subsp. stewartii) of corn and Maize dwarf mosaic virus

open access: yesPest Management Science, Volume 81, Issue 4, Page 1988-1999, April 2025.
Schematic diagram of the single and dual RPA‐CRISPR/Cas12a/13a diagnostic assays for the detection of Pantoea stewartii subsp. stewartii and Maize dwarf mosaic virus. The validated assays provide a useful and sensitive molecular tool for detecting two quarantine pathogens of maize within a minimal resource framework suitable for fast‐tracking the ...
Qian Tian   +6 more
wiley   +1 more source

A novel isolated phage targeting Pseudomonas aeruginosa demonstrates therapeutic potential. [PDF]

open access: yesPLoS One
Wang X   +6 more
europepmc   +1 more source

Clinical implications of cefoperazone-sulbactam MIC values in <i>Pseudomonas aeruginosa</i> bloodstream infections: a multicentre study. [PDF]

open access: yesJAC Antimicrob Resist
Shie SS   +13 more
europepmc   +1 more source

Developing Gingerol-Based Analogs against Pseudomonas aeruginosa Infections

open access: yesACS Omega
Taehyeong Lim   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy